Zimmer Biomet Holdings
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 2 weeks.
- Recent price momentum is +8.6% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 4.1% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2849 U.S. stocks StockVane covers.
Last computed: 2026-11-21 14:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 25.5x | Better than 29% |
| Forward P/E | 19.1x | Better than 41% |
| Price / Sales | 2.3x | Better than 52% |
| P/E vs own 5-yr range | 53rd pctl | Better than 57% |
Growth B+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 5.9% | Better than 50% |
| Net income CAGR (3Y) | 45.0% | Better than 86% |
| Free cash flow CAGR (3Y) | 10.0% | Better than 52% |
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 69.7% | Better than 83% |
| Operating margin | 16.5% | Better than 69% |
| Net margin | 8.6% | Better than 55% |
| Return on equity | 5.6% | Better than 38% |
| Return on invested capital | 4.9% | Better than 44% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 0.4% | Better than 74% |
| 6-month return | 18.9% | Better than 82% |
| 12-month return (ex latest month) | 8.3% | Better than 44% |
| Distance below 52-week high | 10.2% | Better than 83% |
Financial Health B
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.0x | Better than 55% |
| Debt to assets | 32.6% | Better than 37% |
| Interest coverage | 3.8x | Better than 50% |
| Free cash flow / net income | 201.4% | Better than 77% |
Analyst View D
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 26.7% | Better than 13% |
| Upside to average target | 13.3% | Better than 20% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 101.47
- Open
- 102.72
- Day range
- 100.82 - 103.87
- Avg price
- 101.70
- Volume
- 2.96M
- Turnover
- 300.98M
- Turnover ratei
- 1.57%
- Volume ratioi
- 1.12
- Amplitudei
- 3.00%
- 52-week rangei
- 78.70 - 112.55
Valuation
- P/Ei
- 28.48
- P/E (TTM)i
- 25.53
- P/Bi
- 1.50
- EPSi
- 3.55
- Book value / shi
- 67.19
- Net profit
- 671.85M
- Net assets
- 12.72B
Share structure
- Market cap
- 19.13B
- Float capi
- 19.07B
- Shares out
- 189.25M
- Float sharesi
- 188.65M
Dividend & listing
- Div yield (TTM)i
- 0.95%
- Dividend (TTM)
- 0.96
- Listing date
- 1970-01-01
10.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+11.17M net over the window
Short interest
- Shares short
- 7.85M
- % of floati
- 4.11%
- Days to coveri
- 3.89
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Zimmer Biomet Holdings (ZBH)?
Zimmer Biomet Holdings last traded at 101.10. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Zimmer Biomet Holdings's market cap?
About 19.13B.
What is the P/E ratio of Zimmer Biomet Holdings?
The trailing twelve-month P/E is 25.53, below its own 5-year average of 46.33 — in the middle of its historical range (53.07% percentile). See the Valuation tab for the full history.
Does Zimmer Biomet Holdings pay a dividend?
Yes. The trailing dividend yield is 0.95%. Per-share dividends have risen or held for 10 straight years through 2025. See the Dividends tab for the full payment history.
Is Zimmer Biomet Holdings a buy according to analysts?
The consensus of 15 analysts is a Buy rating, with an average 12-month price target of 114.50, which implies 13.3% upside from the current price. This is not investment advice.
What is Zimmer Biomet Holdings's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Zimmer Biomet Holdings a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Zimmer Biomet Holdings discussion 0 comments